Published in Stem Cells Transl Med on April 09, 2013
T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs (Treg) | NCT01210664
Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients | NCT00646724
Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nat Med (2014) 1.52
MSC microvesicles for the treatment of lung disease: a new paradigm for cell-free therapy. Antioxid Redox Signal (2014) 0.95
Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus. J Diabetes Res (2015) 0.95
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies. BMC Med (2015) 0.91
Concise review: pluripotent stem cell-based regenerative applications for failing β-cell function. Stem Cells Transl Med (2014) 0.88
Stem cell therapy for the treatment of parasitic infections: is it far away? Parasitol Res (2013) 0.82
Recent advances of stem cell therapy for retinitis pigmentosa. Int J Mol Sci (2014) 0.81
Glibenclamide attenuates myocardial injury by lipopolysaccharides in streptozotocin-induced diabetic mice. Cardiovasc Diabetol (2014) 0.80
Diet, Microbiota and Immune System in Type 1 Diabetes Development and Evolution. Nutrients (2015) 0.80
Mesenchymal stem cells help pancreatic islet transplantation to control type 1 diabetes. World J Stem Cells (2014) 0.78
Benefits of healthy adipose tissue in the treatment of diabetes. World J Diabetes (2014) 0.77
Current progress of human trials using stem cell therapy as a treatment for diabetes mellitus. Am J Stem Cells (2016) 0.76
Immunotherapy for type 1 diabetes. J Endocrinol Invest (2017) 0.76
Residual β-Cell Function Predicts Clinical Response After Autologous Hematopoietic Stem Cell Transplantation. Stem Cells Transl Med (2016) 0.75
Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes. PLoS One (2016) 0.75
Human Bone Marrow Subpopulations Sustain Human Islet Function and Viability In vitro. Br J Med Med Res (2015) 0.75
The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis. Stem Cells Int (2015) 0.75
Single-donor islet transplantation in type 1 diabetes: patient selection and special considerations. Diabetes Metab Syndr Obes (2017) 0.75
Identification of Aging-Associated Gene Expression Signatures That Precede Intestinal Tumorigenesis. PLoS One (2016) 0.75
Type 1 Diabetes Mellitus Donor Mesenchymal Stromal Cells Exhibit Comparable Potency to Healthy Controls In Vitro. Stem Cells Transl Med (2016) 0.75
Chitosan-assisted differentiation of porcine adipose tissue-derived stem cells into glucose-responsive insulin-secreting clusters. PLoS One (2017) 0.75
Human induced pluripotent stem cells free of vector and transgene sequences. Science (2009) 17.16
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell (2010) 14.18
Induced pluripotent stem cells generated without viral integration. Science (2008) 13.38
Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell (2009) 11.65
Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol (2008) 10.60
Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature (2009) 9.29
Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell (2009) 7.62
Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell (2010) 7.16
Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell (2011) 6.11
Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med (1986) 6.11
Retracted Spontaneous human adult stem cell transformation. Cancer Res (2005) 4.95
Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood (2003) 4.43
A nonviral minicircle vector for deriving human iPS cells. Nat Methods (2010) 4.42
The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol (2009) 4.36
Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev (2011) 4.15
Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A (2006) 3.48
Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A (2009) 3.43
Sarcoma derived from cultured mesenchymal stem cells. Stem Cells (2006) 3.40
Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med (2012) 3.27
Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell (2009) 3.02
Nonmalignant late effects after allogeneic stem cell transplantation. Blood (2003) 2.95
Concise review: Adipose-derived stem cells as a novel tool for future regenerative medicine. Stem Cells (2012) 2.58
Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells (2005) 2.52
Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes (2012) 2.40
Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood (2005) 2.39
Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes (2008) 2.25
A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS One (2012) 2.24
Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med (2012) 2.19
Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol (2009) 2.15
Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nat Biotechnol (2011) 2.08
Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp Mol Pathol (2005) 2.07
Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation (2010) 2.02
Natural history of beta-cell function in type 1 diabetes. Diabetes (2005) 1.98
Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res (2005) 1.86
Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines. PLoS One (2012) 1.76
How does type 1 diabetes develop?: the notion of homicide or β-cell suicide revisited. Diabetes (2011) 1.74
Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant (2008) 1.68
IL-17 immunity in human type 1 diabetes. J Immunol (2010) 1.67
Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc Natl Acad Sci U S A (2010) 1.67
Human adipose stem cells: current clinical applications. Plast Reconstr Surg (2012) 1.62
Mixed chimerism and growth factors augment β cell regeneration and reverse late-stage type 1 diabetes. Sci Transl Med (2012) 1.59
Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia (2009) 1.51
Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function. Transplantation (2010) 1.47
Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells. BMC Med (2012) 1.44
Targeting SOX17 in human embryonic stem cells creates unique strategies for isolating and analyzing developing endoderm. Cell Stem Cell (2011) 1.41
Concise review: Mesenchymal stem cell treatment of the complications of diabetes mellitus. Stem Cells (2011) 1.35
Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chin Med J (Engl) (2007) 1.35
Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol Med (2011) 1.31
Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev (2011) 1.30
Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J Bone Miner Res (2005) 1.29
Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes. Diabetes (2010) 1.24
Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes. Nat Rev Drug Discov (2011) 1.21
Immunological applications of stem cells in type 1 diabetes. Endocr Rev (2011) 1.20
Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells. Autoimmunity (1998) 1.18
The rise and fall of insulin secretion in type 1 diabetes mellitus. Diabetologia (2006) 1.18
Cellular origins of beta-cell regeneration: a legacy view of historical controversies. J Intern Med (2009) 1.16
Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for insulin-dependent diabetes mellitus. Stem Cells Int (2010) 1.15
Integration-free iPS cells engineered using human artificial chromosome vectors. PLoS One (2011) 1.13
Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes. Diabetes (2012) 1.13
Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation. Endocr Rev (2008) 1.12
Co-transplantation of mesenchymal stem cells maintains islet organisation and morphology in mice. Diabetologia (2011) 1.11
Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats. Transplant Proc (2009) 1.11
Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain. Endocr Rev (2011) 1.10
Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocr J (2012) 1.08
Concise review: mesenchymal stem cells for diabetes. Stem Cells Transl Med (2011) 1.06
Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I. Bone Marrow Transplant (2010) 1.06
Combined islet and hematopoietic stem cell allotransplantation: a clinical pilot trial to induce chimerism and graft tolerance. Am J Transplant (2008) 1.05
Recent advances and prospects in the differentiation of pancreatic cells from human embryonic stem cells. Diabetes (2010) 1.05
Islet-like cell aggregates generated from human adipose tissue derived stem cells ameliorate experimental diabetes in mice. PLoS One (2011) 1.05
Stem cell approaches for diabetes: towards beta cell replacement. Genome Med (2011) 1.02
Elimination of insulitis and augmentation of islet beta cell regeneration via induction of chimerism in overtly diabetic NOD mice. Proc Natl Acad Sci U S A (2007) 1.02
Autologous hematopoietic stem cell transplantation for type 1 diabetes. Ann N Y Acad Sci (2008) 1.01
Transdifferentiation of human adipose tissue-derived stromal cells into insulin-producing clusters. J Artif Organs (2009) 1.00
The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine. Cell Prolif (2011) 0.99
Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and β-cell differentiation in streptozocin-induced diabetic mice. Cell Transplant (2011) 0.99
Concise review: pancreas regeneration: recent advances and perspectives. Stem Cells Transl Med (2012) 0.98
Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice. Cell Transplant (2012) 0.98
Programming of regulatory T cells from pluripotent stem cells and prevention of autoimmunity. J Immunol (2012) 0.97
Cellular reprogramming: a small molecule perspective. Curr Opin Cell Biol (2012) 0.97
Stem cell sources to treat diabetes. J Cell Biochem (2009) 0.97
Islet transplantation in type I diabetes mellitus. Yale J Biol Med (2012) 0.96
Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery. Exp Mol Med (2012) 0.96
CD24: a novel surface marker for PDX1-positive pancreatic progenitors derived from human embryonic stem cells. Stem Cells (2011) 0.95
Mesenchymal stem cells and islet cotransplantation in diabetic rats: improved islet graft revascularization and function by human adipose tissue-derived stem cells preconditioned with natural molecules. Cell Transplant (2012) 0.94
Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes. Stem Cells Transl Med (2012) 0.94
Combined transplantation of pancreatic islets and adipose tissue-derived stem cells enhances the survival and insulin function of islet grafts in diabetic mice. Transplantation (2010) 0.93
Mesenchymal stem cells express serine protease inhibitor to evade the host immune response. Blood (2010) 0.93
Generation of glucose-responsive, insulin-producing cells from human umbilical cord blood-derived mesenchymal stem cells. Cell Transplant (2011) 0.92
Targeting regulatory T cells in the treatment of type 1 diabetes mellitus. Curr Mol Med (2012) 0.92
Umbilical cord blood: lessons learned and lingering challenges after more than 20 years of basic and clinical research. Arch Med Res (2011) 0.92
Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization. Stem Cells Dev (2011) 0.91
The role of immunosuppression of mesenchymal stem cells in tissue repair and tumor growth. Cell Biosci (2012) 0.91
Human cord blood stem cells and the journey to a cure for type 1 diabetes. Autoimmun Rev (2010) 0.91
Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model. Stem Cells Dev (2012) 0.90
Diabetic ketoacidosis at diagnosis influences complete remission after treatment with hematopoietic stem cell transplantation in adolescents with type 1 diabetes. Diabetes Care (2012) 0.89
Long-term outcome after pancreas transplantation. Curr Opin Organ Transplant (2012) 0.88
Differentiating of banked human umbilical cord blood-derived mesenchymal stem cells into insulin-secreting cells. In Vitro Cell Dev Biol Anim (2010) 0.87
Human embryonic stem cell differentiation into insulin secreting β-cells for diabetes. Cell Biol Int (2012) 0.85
Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20
Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab (2012) 2.22
Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol (2005) 1.54
Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies. Am J Transplant (2003) 1.31
Glucose regulation of insulin gene transcription and pre-mRNA processing in human islets. Diabetes (2007) 1.17
Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation. Endocr Rev (2008) 1.12
Sphingosine 1-phosphate receptor 3 regulates recruitment of anti-inflammatory monocytes to microvessels during implant arteriogenesis. Proc Natl Acad Sci U S A (2013) 1.08
Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling. Cell Calcium (2010) 1.07
The use of non-heart-beating donors for isolated pancreatic islet transplantation. Transplantation (2003) 1.03
Comparison of open, laparoscopic, and hand-assisted approaches to live-donor nephrectomy. Transplantation (2002) 0.99
Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated rats. Am J Physiol Endocrinol Metab (2008) 0.99
Adenoviral graft-nephritis: case report and review of the literature. Transpl Int (2009) 0.95
Liver X receptor agonists augment human islet function through activation of anaplerotic pathways and glycerolipid/free fatty acid cycling. J Biol Chem (2009) 0.92
Complement-binding anti-HLA antibodies and kidney transplantation. N Engl J Med (2014) 0.92
The use of stem cells in liver disease. Curr Opin Organ Transplant (2009) 0.92
The use of stem cells in kidney disease. Curr Opin Organ Transplant (2009) 0.91
Inflammatory blockade improves human pancreatic islet function and viability. Am J Transplant (2005) 0.90
Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Pancreas Transplantation. Diabetes Technol Ther (2011) 0.86
Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation. J Transplant (2011) 0.85
Evaluation of vascular complications of pancreas transplantation with high-spatial-resolution contrast-enhanced MR angiography. Radiology (2007) 0.84
Naturally occurring immunoglobulin M (nIgM) autoantibodies prevent autoimmune diabetes and mitigate inflammation after transplantation. Ann Surg (2012) 0.84
Nocardiosis in a renal transplant recipient following rituximab preconditioning. Ups J Med Sci (2009) 0.84
Pancreatic islet transplantation in type 1 diabetes mellitus: an update on recent developments. Curr Diabetes Rev (2013) 0.84
Adenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection. Cell Transplant (2010) 0.83
Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation. J Transplant (2011) 0.83
Successful PTA and stenting for acute iliac arterial injury following pancreas transplantation. Am J Transplant (2003) 0.83
Overcoming barriers in clinical islet transplantation: current limitations and future prospects. Curr Probl Surg (2013) 0.82
Spatiotemporal oxygen sensing using dual emissive boron dye-polylactide nanofibers. ACS Nano (2014) 0.81
Contrast-enhanced MR angiography after pancreas transplantation: normal appearance and vascular complications. AJR Am J Roentgenol (2005) 0.81
Neoral rescue therapy in transplant patients with intolerance to tacrolimus. Clin Transplant (2002) 0.81
Identification of biomarkers to assess organ quality and predict posttransplantation outcomes. Transplantation (2012) 0.80
Regenerative medicine and tissue engineering: contribution of stem cells in organ transplantation. Curr Opin Organ Transplant (2009) 0.80
Update on islet cell transplantation for type 1 diabetes. Semin Intervent Radiol (2012) 0.80
Multilayer cell-seeded polymer nanofiber constructs for soft-tissue reconstruction. JAMA Otolaryngol Head Neck Surg (2013) 0.79
Natural IgM anti-leucocyte autoantibodies (IgM-ALA) regulate inflammation induced by innate and adaptive immune mechanisms. J Clin Immunol (2014) 0.79
Elderly recipients of hepatitis C positive renal allografts can quickly develop liver disease. J Surg Res (2011) 0.76
Intrathymic islet transplantation in the canine: I. Histological and functional evidence of autologous intrathymic islet engraftment and survival in pancreatectomized recipients. Transplantation (2002) 0.76
Infectious complications in living-donor kidney transplant recipients undergoing multi-modal desensitization. Surg Infect (Larchmt) (2014) 0.75
Donor risk index predicts graft failure reliably but not post-transplant infections. Surg Infect (Larchmt) (2013) 0.75
Impact of Postoperative Venous Thromboembolism on Postoperative Morbidity, Mortality, and Resource Utilization after Hepatectomy. Am Surg (2015) 0.75
Salvage of hyperacute renal transplant hypoperfusion with stent placement: a case report. J Vasc Interv Radiol (2008) 0.75
Pancreas allografts: comparison of three-dimensional rotational angiography with standard digital subtraction angiography. J Vasc Interv Radiol (2008) 0.75
Successful treatment of encrusted cystitis and pyelitis with preservation of renal graft. Transplantation (2004) 0.75